Tissue Microarrays (TMAs)
High-Throughput Validation: Precision-Engineered TMAs for Accelerated Biomarker Discovery
Creative Bioarray provides high-density Tissue Microarrays (TMAs) designed to maximize research efficiency. By assembling hundreds of miniaturized tissue cores onto a single slide, our TMAs enable simultaneous analysis of protein or gene expression across diverse biospecimens under identical experimental conditions, significantly reducing reagent consumption and technical variability.
Product Features
Extensive Cohort Selection
Our portfolio includes multiple cancer types, normal controls, and disease-specific arrays (e.g., neurodegenerative, inflammatory), covering human, NHP, and common laboratory animal models.
Standardized Core Precision
Each TMA is constructed with precise core diameters (typically 0.6mm - 2.0mm) and optimized spacing, ensuring structural integrity and consistent results across IHC, ISH, and FISH applications.
Application-Specific Designs
We offer specialized array formats, including multi-tumor arrays, progression arrays (from normal to metastatic), and custom-configured layouts tailored to your unique study objectives.
Why Choose Our Tissue Microarrays?
Unmatched Statistical Power
- Simultaneous analysis of large cohorts (up to 400+ cores per slide)
- Elimination of slide-to-slide batch effects
- Preservation of limited and precious donor tissues
- Cost-effective screening of experimental therapeutic targets
- High-resolution digital pathology compatible
Verified Clinical Integrity
- Expert pathologist-validated core selection (H&E guided)
- Comprehensive donor clinical data and pathology reports
- Stringent QC for morphology and biomarker antigenicity
- Ethically sourced specimens with full IRB/EC compliance
- Seamless integration with our IHC staining services
A major differentiator of our Tissue Microarray portfolio is the combination of high-density sampling and deep clinical characterization. We ensure that every core represents the specific pathology of interest, providing researchers with a robust platform for statistically significant biomarker validation.
Request a Quote or Custom Solution
Whether you need a validated tumor progression array or a custom-designed TMA featuring specific donor profiles, Creative Bioarray is committed to delivering high-performance solutions backed by technical expertise and ethical sourcing.
Please tell us your target disease indications, required core density, and clinical criteria, and our specialists will help you identify or design the optimal array for your research.
Filters Clear all filters
Species
- Human (742)
- Monkey (7)
- Mouse (16)
- Rat (13)
Source
- Adipose (1)
- Adrenal Gland (2)
- Appendix (2)
- Bladder (6)
- Blood Vessel (1)
- Bone (8)
- Bone Marrow (3)
- Brain (13)
- Breast (16)
- Cartilage (4)
- Cervix (9)
- Colon (116)
- Endometrium (4)
- Esophagus (73)
- Gallbladder (2)
- Heart (7)
- Intestine (160)
- Kidney (24)
- Large Intestine (2)
- Liver (112)
- Lung (48)
- Multiple Organs (82)
- Muscle (3)
- Ovary (8)
- Pancreas (43)
- Penis (5)
- Prostate (11)
- Rectum (42)
- Skin (33)
- Small Intestine (7)
- Smooth Muscle (2)
- Spleen (8)
- Stomach (83)
- Testis (9)
- Thyroid Gland (5)
- Ureter (1)
- Urethra (1)
- Uterus (13)
Disease
- Cancer (696)
- Crohn's Disease (3)
- Gastric Ulcer (4)
- Gastritis (5)
- Hepatitis (8)
- Liver Cirrhosis (17)
- Normal (443)
- Pancreatitis (4)
- Ulcerative Colitis (2)
Description: Penis cancer tissue array with unmatched normal adjacent tissues, 12 cases/24 cores .
Description: Penis disease spectrum (penis tumor progression) tissue array, 59 cases/60 cores .
Description: Penile (penis) carcinoma tissue array, 80 cases/80 cores.
Description: Penis cancer test tissue array, with normal penis control tissues, including TNM, clinical stage ...
Description: Penis cancer test tissue array, with normal tissue as control, including TNM, clinical stage and ...
Description: Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 ...
Description: Testis cancer test tissue array, with normal tissue as control, including TNM and clinical stage, 2 ...
Description: Testis disease spectrum (testicular cancer progression) tissue array, with TNM data, 104 cases/208 ...
Description: Testis cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 ...
Description: Testis cancer tissue array with unmatched normal adjacent tissues, 48 cases/48 cores, with stage ...
Description: Testis tumor tissue array, including TNM, 24 cases/48 cores.
Description: Testis seminoma and lymphoma tissue array, 80 cases/80 cores.
Description: Testis disease spectrum (testicular cancer progression) tissue array, 80 cases/80 cores.
Description: Human cervix tumor (Grade III) and adjacent tissue array. 31 cases, single core per cancer and ...
Description: Human cervix tumor (Grade II) and adjacent tissue array. 31 cases, single core per cancer and ...
Description: Human cervix tumor and adjacent tissue array with TNM stage. 31 cases, single core per cancer and ...
Description: Human cervix tumor and adjacent tissue array with TNM stage. 31 cases, single core per cancer and ...
Description: Human uterus tumor (Grade I, II and III) and adjacent tissue array with TNM stage. 31 cases, single ...